Cell-based high throughput screening assays built in less than two months, and millions of protein drug designs screened in a single experiment.
Isolate rare variants of therapeutic proteins with improved function in intact cells. Increase the specificity of an antibody through mutation and create biosensing antibodies.
Utilizing kinase and protease assays to evolve target specific high throughput screening tools with industry-leading Z-factor scores.
